Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
World Obesity Day, observed on March 4th, emphasizes the dangers of the combined effects of diabetes and obesity, termed ...
Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot ...
Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...
Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...
2d
News-Medical.Net on MSNTirzepatide helps people without diabetes lose 13% body weight in real-world studyA real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...
Professor Arne Astrup is also involved in project to change widely-accepted definition of ultra-processed food ...
Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...
A team of researchers have made a groundbreaking development related to a protein that is naturally produced in the body but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results